Buy new:

₹1,974.00

M.R.P.: ₹2,997.00

Save: ₹1,023.00 (34%)

Inclusive of all taxes

In stock

[{"displayPrice":"₹1,974.00","priceAmount":1974.00,"currencySymbol":"₹","integerValue":"1,974","decimalSeparator":".","fractionalValue":"00","symbolPosition":"left","hasSpace":false,"showFractionalPartIfEmpty":false,"offerListingId":"gjA5MnIW0o5UVVdLW6Fy4gYVNHAvp2equVZH4LMbvYDV1Wh4yz4C2WcJ8x4BlEGVoLSkaD6IjY6ZT%2BGIwLY4VpgvQra%2B5m1Gkh3u4TVL2xIezLtrPZVdbSeVz%2Ft21HmOaEC2BaTj5XydKL%2B3vxcgg8Ctl3ai486Cz%2Be7vaxCTBvsJoxxS%2BexHw%3D%3D","locale":"en-IN","buyingOptionType":"NEW"}]

₹₹1,974.00 () Includes selected options. Includes initial monthly payment and selected options. Details

Sold by Bookswagon and Fulfilled by Amazon.

Secure transaction

Add gift options

Have one to sell?

Sell on Amazon

Flip to back Flip to front

See this image

Follow the Author

John Carreyrou

Bad Blood: Secrets and Lies in a Silicon Valley Startup Hardcover – Import, 31 May 2018

by John Carreyrou (Author)

4.6 37,859 ratings

See all formats and editions

Price

New from

Kindle Edition

"Please retry"

₹189.62

—

Audible Audiobook, Unabridged

"Please retry"

₹0.00

Free with your Audible trial

Hardcover

"Please retry"

₹569.00

₹565.00

Hardcover, Import, 31 May 2018

₹1,974.00

Paperback

"Please retry"

₹453.00

₹381.45

Audio CD, Unabridged

"Please retry"

—

EMI starts at ₹96 per month. EMI starts at ₹96. No Cost EMI available EMI options

Save Extra with 3 offers

No Cost EMI: Avail No Cost EMI on select cards for orders above ₹3000 Details

Bank Offer: 5% Instant Discount up to INR 250 on HSBC Cashback Card Credit Card Transactions. Minimum purchase value INR 1000 Details

See 1 more

Free Delivery

The product is eligible for Free delivery. Learn more

What is Pay on Delivery (Cash/Card)?

Pay on Delivery (Cash/Card) payment method includes Cash on Delivery (COD) as well as Debit card / Credit card / Net banking payments at your doorstep.

10 days Replacement

Replacement Reason	Replacement Period	Replacement Policy
Physical Damage, Defective, Wrong and Missing Item	10 days from delivery	Replacement

Know More

Amazon Delivered

Amazon directly manages delivery for this product. Order delivery tracking to your doorstep is available.

Your transaction is secure

We work hard to protect your security and privacy. Our payment security system encrypts your information during transmission. We don’t share your credit card details with third-party sellers, and we don’t sell your information to others. Learn more

Great on Kindle

Great Experience. Great Value.

Enjoy a great reading experience when you buy the Kindle edition of this book. Learn more about Great on Kindle, available in select categories.

View Kindle Edition

Purchase options and add-ons

'I couldn’t put down this thriller . . . the perfect book to read by the fire this winter.' Bill Gates, '5 books I loved in 2018' WINNER OF THE FINANCIAL TIMES/MCKINSEY BUSINESS BOOK OF THE YEAR AWARD 2018 The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. In Bad Blood, John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley. Now to be adapted into a film, with Jennifer Lawrence to star. 'Chilling . . . Reads like a West Coast version of All the President’s Men.' New York Times Book Review

Print length

320 pages
Language

English
Publisher

Picador
Publication date

31 May 2018
Reading age

18 years and up
Dimensions

16.2 x 3.5 x 24.1 cm
ISBN-10

1509868062
ISBN-13

978-1509868063
See all details

Frequently bought together

Bad Blood: Secrets and Lies in a Silicon Valley Startup

₹1,974.00

Get it by Friday, June 9

In stock.

Sold by Bookswagon and ships from Amazon Fulfillment.

+

Empire of Pain: The Secret History of the Sackler Dynasty

₹2,080.00

Get it Jun 21 - 24

Ships from and sold by Bookswagon.

+

The Cult of We: WeWork, Adam Neumann, and the Great Startup Delusion

₹1,608.00

Get it by Wednesday, June 7

Only 2 left in stock.

Sold by Cocoblu Retail and ships from Amazon Fulfillment.

Total price:

To see our price, add these items to your cart.

Try again!

Details

Added to Cart

Some of these items are dispatched sooner than the others.

Show details Hide details

Choose items to buy together.

Katherine Eban
816
Paperback
10 offers from ₹422.89
Patrick Radden Keefe
9,996
Paperback
22 offers from ₹456.88
Reeves Wiedeman
4,109
Paperback
8 offers from ₹355.00
Jack Farchy
2,313
Paperback
13 offers from ₹402.00
Ben MacIntyre
29,011
Paperback
in Cold War
8 offers from ₹405.00
Tom Wright Bradley Hope
6,563
Paperback
4 offers from ₹413.00

Special offers and product promotions

5% Instant Discount up to INR 250 on HSBC Cashback Card Credit Card Transactions. Minimum purchase value INR 1000 Here's how
No cost EMI available on select cards. Please check 'EMI options' above for more details. Here's how
Get GST invoice and save up to 28% on business purchases. Sign up for free Here's how

Popular Highlights in this book

What are popular highlights?

“The presence of the same or similar delusional ideas in two persons closely associated with one another.”
Highlighted by 1,247 Kindle readers
Like her idol Steve Jobs, she emitted a reality distortion field that forced people to momentarily suspend disbelief.
Highlighted by 1,137 Kindle readers
He was reminded of an old saying: “When you strike at the king, you must kill him.”
Highlighted by 1,027 Kindle readers

Product description

Review

A dazzling story of deception in Silicon Valley . . . It is a tale of heroic cupidity on a scale that made the very best and the very brightest look like the very, very foolish . . . You will not be able to put this book down. Source: Washington Post

Riveting . . . a blistering critique of Silicon Valley, a kind of nonfiction corollary to Dave Eggers's The Circle . . . compelling . . . [Carreyrou's] unmasking of Theranos is a tale of David and Goliath . . . The real heroes, though, are his sources: the young scientists who worked at the company and risked their reputations and careers by voicing their concerns. Were it not for their courage, Theranos might still be testing blood today Author: David Crow Source: Financial Times

I couldn’t put down this thriller with a tragic ending . . . a book so compelling that I couldn’t turn away . . . This book has everything: elaborate scams, corporate intrigue, magazine cover stories, ruined family relationships, and the demise of a company once valued at nearly $10 billion . . . No wonder Hollywood is already planning to turn it into a movie. Author: Bill Gates, '5 books I loved in 2018'

If you’re looking for an engaging non-fiction read, look no further than Bad Blood . . . a pacy, compelling narrative about white-collar crime that’s as incredible as any work of fiction. Source: Irish Times

Carreyrou tells the story virtually to perfection . . . Bad Blood reads like a West Coast version of All the President’s Men. Source: New York Times

In this Silicon Valley drama, he opens his reporter’s notebook to deliver a tale of corporate fraud and legal browbeating that reads like a crime thriller. Author: The 10 Best Nonfiction Books of 2018 Source: TIME

Gripping . . . Carreyrou presents the scientific, human, legal and social sides of the story in full . . . He unveils many dark secrets of Theranos that have not previously been laid bare. Source: Nature

Gripping . . . It is a parable, with all the usual, delicious ingredients of human folly: greed, pride, vanity, lust, anger. Above all, it is an analysis of the phenomenon of hype. Source: Daily Telegraph

Simply one of the best books about a startup ever. Source: Forbes

Bad Blood reveals a crucial truth: outside observers must act as the eyes, the ears and, most importantly, the voice of Silicon Valley’s blind spot . . . It gambled not with our smart phones, our attention or our democracy, but with people’s lives. Source: Paste

From the Author

John Carreyrou is a member of the Wall Street Journal’s investigative reporting team. He joined the Journal in 1999 and has been based in Brussels, Paris, and New York for the paper. John has covered a number of topics during his career, ranging from Islamist terrorism when he was on assignment in Europe to the pharmaceutical industry and the US healthcare system. His reporting on corruption in the field of spine surgery led to long prison terms for a California hospital owner and a Michigan neurosurgeon. His reporting on Theranos, a blood-testing startup founded by Elizabeth Holmes, was recognized with a George Polk award, and is chronicled in his book Bad Blood: Secrets and Lies in a Silicon Valley Startup. Born in New York and raised in Paris, he currently resides in Brooklyn with his wife and three children.

Product details

Publisher ‏ : ‎ Picador (31 May 2018)
Language ‏ : ‎ English
Hardcover ‏ : ‎ 320 pages
ISBN-10 ‏ : ‎ 1509868062
ISBN-13 ‏ : ‎ 978-1509868063
Reading age ‏ : ‎ 18 years and up
Item Weight ‏ : ‎ 590 g
Dimensions ‏ : ‎ 16.2 x 3.5 x 24.1 cm

Best Sellers Rank: #660,192 in Books (See Top 100 in Books)
- #839 in Journalism Books
- #4,813 in True Accounts (Books)
- #5,802 in Industries

Customer Reviews:
4.6 37,859 ratings

About the author

Follow authors to get new release updates, plus improved recommendations.

John Carreyrou

Brief content visible, double tap to read full content.

Full content visible, double tap to read brief content.

John Carreyrou is a Pulitzer Prize-winning reporter and a nonfiction author. His first book, "Bad Blood: Secrets and Lies in a Silicon Valley Startup," chronicles Silicon Valley's biggest fraud. Please direct any speaking queries to speakers@penguinrandomhouse.com

Customer reviews

4.6 out of 5

37,859 global ratings

5 star		70%
4 star		23%
3 star		4%
2 star		1%
1 star		1%

How are ratings calculated?

Reviews with images

See all customer images

Top reviews from India

There was a problem filtering reviews right now. Please try again later.

SUDHIR BHARGAVA

Reads like a thriller

Reviewed in India 🇮🇳 on 31 May 2023

Verified Purchase

I finished it cover to cover over 5 working days using my commute time in the metro. Very well constructed and narrated. I wonder what goes in the heads of fraudsters. With almost no invention to talk of or technology, the who’s who invested and even defended despite evidence to the contrary. I read yesterday she will turn up at prison, finally to serve her sentence. “Story telling” is a very very powerful art.

Helpful

Tsewang Thar

The tremendous courage of Elizabeth.

Reviewed in India 🇮🇳 on 26 April 2023

Verified Purchase

I would like to finish oh first

Helpful

Amazon Customer

Not an waste of time 😉

Reviewed in India 🇮🇳 on 26 November 2022

Verified Purchase

Ok iam finally finished this Book....if you are an medical student definitely you have to read this book , Even for non medical students also it's worth to read and understand how the paramedical companies working....There are lot of names you have to keep in your mind while going through this book...one life lesson i Learned from this book is, If you fool the people because of your own greedyness and wealth at the end of the day you will really suffer and lost everything that's what happened to the elizabeth Holmes (Bitch)

Helpful

Natarajan Mahalingam

One of the recent pieces of top-notch investigative journalism - don't miss it!

Reviewed in India 🇮🇳 on 11 September 2021

Verified Purchase

One of the top-notch pieces of investigative journalism by John Carreyrou in recent times, the book is a culmination of 3.5 years of John's investigation and reporting on Theranos, the now defunct startup by Elizabeth Holmes. Though I had wind of the type of problems the startup ended up with over the years through news articles, this book encapsulates in precisive details, the events right from the beginning until mid-2018, when the company was dissolved

If books like The Lean startup, Zero to One, The Innovation Stack, and The Right it showed us how startups and entrepreneur's drive an idea or initiative to success, Bad Blood brings out examples of how not-to run a startup, across technical, people-centric, and impact-centric angles. Just like I recommended the former books, I would also recommend Bad Blood as a book that warns any prospective entrepreneur on pitfalls and mindsets that would lead to downfall in a startup culture

John's writing literally transports you, as an invisible viewer, as the events get recorded and at one point in time, you will feel, why you couldn't have stopped what Elizabeth Holmes was trying to do to the characters in the book. John's integrity and moral compass show through, even as he is tried to be intimidated by Theranos lawyers at crucial points in the story. His ethical stance against letting go of sources and withstanding fire from the dragon's mouth are inspiring, to say the least. John's character descriptions and the capturing of emotions all across the book is one of the strong points of his writing that help readers to visualize the characters in their minds vividly

All said, I am happy that I had the chance to read the book, before the movie potentially in the works gets released, with Jennifer Lawrence set to play Elizabeth Holmes (at the time of my writing this)

Helpful

Kartik Matmari

Greed is NOT good, especially when you are dealing with lives.

Reviewed in India 🇮🇳 on 3 February 2022

Verified Purchase

Book Review : Greed is NOT good, especially when you are dealing with lives.

I was 2 years late actually to read this fascinating “business thriller”. I was awed by the initial success story of Theranos and Elizabeth Holmes, touted as the next Steve Jobs. And from 2016 onwards the dirty details started coming out about Theranos and the whole saga of its Silicon Valley deception that featured the greatest stalwarts of the VC community, the Academia, the federal government, the Military, the R&D researchers. How Walmart and Safeway were taken for a ride. The greatest names in Law got involved.

John Carreyrou “Bad Blood” is fabulous. If you haven’t read it then please do. Dec 2021, the first sentence was out in the case, and much more is due. It’s a story of how greed is always not good and how charm, charisma and cunning can come together to fool some of the “best minds”. Its "fake-it-till-you-make-it" at its worst!. From Zero to Billions to Zero.

Bill Gates had recommended this in his yearly booklist in 2019. In his words – “ ‘Bad Blood’ tackles some serious ethical questions, but it is ultimately a thriller with a tragic ending. It’s a fun read full of bizarre details that will make you gasp out loud.”

Helpful

Amazon Customer

A book that can be appreciated for its research and perfection

Reviewed in India 🇮🇳 on 27 March 2021

Verified Purchase

At its core, Bad Blood is a story of Elizabeth Holmes, her vision, and the boundaries she crossed to bring it to fruition, leading to ruined lives, friendships, and trust.

At a glance, it seems like any other story about a delusional person surrounded by yes-men in power, trying to put a dent in the planet. But it is so much more. John Carreyrou's in-depth research into the matter shines throughout the book. I was a little skeptical going in, ready to skim through the jargons that I was sure would make no sense. But John's writing was so accessible that it surprised me when mental images conjured up about the Theranos devices and anger raised every time he mentioned Sunny Balwani and his management style.

I did some initial research on Elizabeth before picking up the book, and I was left with a sinking feeling. 'How did no one realize what was happening for so long? The board members specifically.

John has explored that very well. I could not keep this book down. After an initial glance at the first 50 pages, I burned through the rest in one day. The way John has weaved the story by taking hundreds of moving pieces into a narrative is commendable. I am so looking forward to watching this played in a movie.

Reviewed in India 🇮🇳 on 2 August 2022

Verified Purchase

What a fascinating story. They say that truth is stranger than fiction. Indeed it was like reading a thriller. The book outlines the story of Theranos - the caustic work environment, the fraud, and how the courage of some of the employees in spite of threats helped reveal the truth.

Helpful

Top reviews from other countries

Tim de Hoog

A thrilling read!

Reviewed in the Netherlands 🇳🇱 on 10 December 2022

Verified Purchase

Reads like a thriller. Excellent analysis and behind the scenes of Theranos. A hard lesson in what greed, corruption and blind faith can do. Also shows you how vital a free and independent media is to bring fraud like Theranos to justice.

Natalia Rice

The best read of the season; the author deserves an award.

Reviewed in the United Kingdom 🇬🇧 on 2 July 2018

Verified Purchase

Drop everything you're doing and start reading it. It's an utterly engaging mix of genres - investigative journalism, psychology (at times psychiatry), organisational behaviour, business & science reporting, and a story of worst and best of the humankind. I've cancelled meetings and events, delayed going to bed just to keep reading this book - the story is almost surreal, and it's hard to believe it really happened, and yet it did.
I'd like to compliment the author. The depth of the investigation is extraordinary; but most importantly, the narration is done in this perfect documentary style when even the most chilling events are described with high precision but without falling into emotional judgement.

I also would like to say a big thank you to all the sources and contributors who made this book possible. You're very brave people; I applaud your courage and ethics.

112 people found this helpful

David

If something sounds too good to be true it probably is.

Reviewed in the United Kingdom 🇬🇧 on 3 April 2019

Verified Purchase

I missed this book when it launched, but Alex Gibney's excellent 2019 HBO doucmentry 'The Inventor: Out for blood in Silicon Valley' prompted my purchase.
Carryrou's book covers three and a half years of investigation into Theranos, its founder Elizabeth Holmes and her meteoric rise and spectacular fall in the obsessive pursuit of a dream. Its a fascinating read and Carryrou uses his research to tell the story from the beginning. The story of his investigations as a Wall Street Journal reporter follows the cronological order of events and is documented towards the end of the book.

Essentially, Elizabeth Holmes developed a start-up in Silicon Valley where she attempted to develop a device which could provide multiple blood test analyses for a range of conditions and diseases in a box not much larger that a large bread-bin. For the user only a small pinprick of blood was required to complete all these tests.
This would be a game changer. Some day, every home could have one and for a small charge could carry out blood tests and have them analysed almost immediately, providing early warning of developing conditions. What's not to like? Nothing it seemed.
What makes this book so fascinating, as well as the central characters and story, are the themes it explores such as:

Greed and denial
The historty of Silicon Valley start-ups is one where investors always try and get in at the beginning of potentially novel ideas and make a killing. Think Google, Facebook and Uber. Two things drive this. The idea and the confidence/ expertise/drive of those taking it forward. In the case of Theranos Elizabeth Holmes force of personality outweighed any doubts about the concept or the execution. However at the time she started Theranos, she was 19 and a Stanford dropout with no experience in blood testing whatsoever, beyond a grand idea and good connections.
Holmes exerted an almost Svengali like hold of the people in her orbit. This is partly to do with her physical appearance. Tall; striking blue unblinking eyes; dessed in black turtle necks (a la Steve Jobs) and speaking in a baritone voice. Supremely confident in both her idea and herself she managed to persuade and recruit a Board of former ex- Government Cabinet members; a 4 star General (Jim Mattis of Trump fame) and big name investors, who blinded by either the promise of the idea or the money to be made from it, were sufficiently incurous as to seek the detail of how this invention actually worked. People and organisations such as Walgreens were happy to put hundreds of millions of dollars investment into Theranos without demanding independent expert due diligence of the product.
At the time of Theranos's demise it was valued as a private company at $9bn, with Holmes's share of that valuation at $4.5. Up to that point no investor in Theranos had seen the inner working of the product or questioned the fabulous claims made for it. Neither had any member of her company Board.

Secrecy and lies
Holmes and her senior executive partner were secretive to the point of paranoia over their idea. Two reasons for this. First they were genuinely concerned about their ideas being stolen, but as time went on and they could not get their invention to work the secrecy hid a raft of corner cutting, false promises and outright lies as to how the equipment was performing. Only those in Theranos working on the project could see how far from the truth the claimes Holmes made for the product and its readiness to market actually were. Some turned a blind eye while those with professional or ethical concerns were either fired or left, all under rigourous confidentiality clauses.
This secrecy coupled with an agressive management style also stifiled the creative initiative of the Theranos team. Knowledge was power and developers were deliberately siloed to ensure they only worked on their own area so the ability to share thinking across the firm was severly limited.

Weaponising the law
What I found perhaps most shocking of all is the way the agressive use of the threat of litigation is used to force compliance, especially against those who cannot financially afford to fight their corner. The lawyers who command the most fees are the legal pit bulls of the industry. Holmes spares no expense in protecting her secrets and covering her lies with the determined use of agressive legal firms and the threats of legal action to force whistleblowers to keep silent. This extends to Carryrou as well. Of the $900m raised by Holmes in her third funding round, $300m went on lawyers fees!

Regulatory incuriousity
The FDA and other regulators seemed broadly incurious about the claims for this machine and remained so until things started to go badly wrong when what was essentially an idea at prototype stage went live to the public. The degree to which private companies can avoid such scrutiny is alarming.

The debate is still ongoing as to whether Holmes deliberately misled or had sociopathic tendencies. The story is not over. She is now charged with alleged Federal and SEC crimes which carry up to 20 years in prison.

I highly recommend this book, which I think will become a textbook on leadership, governance failure and greed.I also recommend Gibney's HBO documentary which brings to life the people and events in the book, not least Elizabeth Holmes herself. It also adds visual detail on the development of the blood testing device in the way Carryrou's book can not.

Hope this is helpful.

29 people found this helpful

Paul Dyer

Shocking but depressingly familiar

Reviewed in the United Kingdom 🇬🇧 on 21 June 2020

Verified Purchase

I was desperately keen to read this book after following the story emerging in real time in the news channels a few years back, and also having spent more than 3 decades in the hi-tech industry myself, which included many jaunts to Silicon Valley. The hi-tech sector is a fascinating yet brutal place to be. It is a fast-paced, exciting, and dynamic industry rife with hype and frequently driven by unrealistic expectations which result from people spinning downright lies. These people are smart, intelligent, well-polished individuals who somehow mysteriously rise to great heights within organisations and public perception. Devoid of competence themselves, they leave a trail of destruction and hardship in their wake but personally survive to even bigger and better things by having golden parachutes and being long gone from their posts by the time the brown stuff finally hits the fan. It can also be genuinely argued that without such hype and expectations, many ultimately successful developments and projects which run massively over-budget and are considerably delayed would never have been funded in the first place if those backing the venture had known exactly what costs and pain they were committing themselves to.

And so, we come to the story of Theranos, Elizabeth Holmes and Sunny Balwani. I have encountered numerous individuals like these two in my career and remain amazed that so many people continue to get taken in by such thoroughly disingenuous and reprehensible characters. There are a couple of pertinent factors at play here. Fundamentally, lying is a trait common to all human beings, and even in a case where it is prolific and sustained over a long period of time as here, it is not a criminal offence. It is only when harm of some kind results, be it physical or financial, that legal action can be taken, and even then those in the dock are innocent until proven guilty, which can be an insurmountable burden for the victims. The other factor seems to be that human beings in general instinctively believe and trust what they are told, based on their perception of the other party, and even when such perception is wrong, having been a carefully crafted lie, people only hear what they want to hear. I know from bitter experience that it can be near impossible to call these people out without getting yourself branded as negative, cynical, a glass half-fuller, not a team player etc. etc.

This book goes into detail and one conjures up little sympathy for the high-profile investors who ended up with an early bath in this sorry saga. These were all intelligent educated people who should have undertaken appropriate due diligence on the opportunity they were presented with but didn’t. Either they believed the web of lies they were fed by Theranos or assumed without verifying it that their fellow investors had undertaken due diligence, thus negating the need to repeat it. Unbelievably, even when warning bells were rung directly under their noses by various Theranos employees, most failed to take notice or instigate any action to seek out the facts. Arrogance combined with ignorance is a powerful combination that is hard to tackle. And let’s be honest; these guys were in it to make a financial killing anyway so what does that say about their own greed.

This book stands out as fabulous investigative journalism. It reads almost like a thriller. The reader can’t wait to learn what happens next, whilst continually wondering if the good guys are going to win at the end of the day. And who are the good guys in such a story anyway….?

It will be remarkably interesting to see what happens in the aftermath. Holmes and Balwani are to be tried separately after being indicted on multiple counts of fraud for misleading investors, government officials and consumers about Theranos' technology. Balwani has said he will fight. Holmes denies any wrongdoing and has pleaded not guilty. She is awaiting criminal trial and has unsurprisingly attached herself to a new love interest from a wealthy family which gives her access to plenty of finance and top-notch legal firepower to mount her defence. She has already created a picture that government regulators overreacted when a reporter from The Wall Street Journal pushed them to investigate and misunderstood what was going on at Theranos. Her other line will be that she did not personally benefit from what took place at Theranos under her leadership; if there were no proceeds of crime, there is no premeditated crime to answer for etc. However, that seems contentious given the executive lifestyle she enjoyed at the company’s expense, including a full funded home and car, luxury accommodation, travel by private jet, and a gaggle of personal bodyguards 24/7.

Read this book if you want an insight into the way that some hi-tech companies raise and (mis)spend money with gullible investors. It is both shocking and sad to see just how low smart and highly placed people stoop in pursuit of their own dreams. This is an excellently documented modern example of the outrageous lengths that unsavoury solipsistic individuals with dubious moral compasses and an overwhelming urge to attain personal wealth and recognition will go…. whilst destroying hard-working people’s lives and careers in the process. A thoroughly enjoyable read and highly recommended.

13 people found this helpful

@Timothy_Hughes

Playing fast and loose with patients data is morally wrong, but where did it all go wrong?

Reviewed in the United Kingdom 🇬🇧 on 5 May 2022

Verified Purchase

I must admit that having finished this book and put it down, I’ve had to take time and process what John Carreyrou has written.

John is a journalist at the Wall Street Journal and he got a “sniff” that things weren’t right at the company, Theranos. It’s CEO, Elizabeth Holmes, in October 2014 was on the front cover of Forbes magazine and her net worth was $4.5 billion. Following Carreyrou’s investigation, Forbes revised this estimate to zero in 2016.

So where did it all go wrong? Well, that’s why you need to read the book.

Carreyrou details the culture of fear within the business, the culture of selling something that didn’t exist. Now remember, that what Theranos did was test blood.

Now, if you went for a blood test, you would expect this to be with tried and tested technology and you would believe the result that came back. If the result came back and it suggested you might have prostate cancer, your world would change. Just think about the things that would go through your head. Playing fast and loose with patient’s data is morally wrong, but where did it all go wrong?

3 people found this helpful

See all reviews

AbeBooks Books, art & collectibles	Amazon Web Services Scalable Cloud Computing Services	Audible Download Audio Books	DPReview Digital Photography	IMDb Movies, TV & Celebrities

Shopbop Designer Fashion Brands	Amazon Business Everything For Your Business	Prime Now 2-Hour Delivery on Everyday Items	Amazon Prime Music 100 million songs, ad-free Over 15 million podcast episodes

Buy new:

₹1,974.00

Follow the Author

Bad Blood: Secrets and Lies in a Silicon Valley Startup Hardcover – Import, 31 May 2018

Save Extra with 3 offers

10 days Replacement

Replacement Instructions

Purchase options and add-ons

Frequently bought together

Customers who viewed this item also viewed

Special offers and product promotions

Product description

Review

From the Author

From the Inside Flap

From the Back Cover

About the Author

Product details

About the author

John Carreyrou

Customer reviews

Reviews with images

Top reviews from India

There was a problem filtering reviews right now. Please try again later.

Top reviews from other countries

Buy new: ₹1,974.00

Follow the Author

Bad Blood: Secrets and Lies in a Silicon Valley Startup Hardcover – Import, 31 May 2018

Save Extra with 3 offers

10 days Replacement

Replacement Instructions

Purchase options and add-ons

Frequently bought together

Customers who viewed this item also viewed

Special offers and product promotions

Product description

Review

From the Author

From the Inside Flap

From the Back Cover

About the Author

Product details

About the author

John Carreyrou

Customer reviews

Reviews with images

Top reviews from India

There was a problem filtering reviews right now. Please try again later.

Top reviews from other countries

Buy new:

₹1,974.00